TREATMENT FREE REMISSION ASSESSMENT AFTER DISCONTINUATION OR DOSE REDUCTION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS. DiSCUSS
TREATMENT FREE REMISSION ASSESSMENT AFTER DISCONTINUATION OR DOSE REDUCTION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS. DiSCUSS